$EL

FRIBOURG PAUL J sold $10.0M of EL (indirect holdings)

FRIBOURG PAUL J sold 103,000 indirectly-held shares of ESTEE LAUDER COMPANIES INC (EL) at an average of $97.56 ($96.78–$98.79, $10.05M total) across 4 trades over 2026-09-11 to 2026-09-14.

Original reporting
SEC EDGAR · FRIBOURG PAUL J
Published Sep 15, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EL
Bearish
medium confidence
Mentioned
$EL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ELBearishLow
01

Why it matters

The sale reduces insider ownership, which some investors view as a negative signal.

02

Market read

Directors' insider sales are monitored for potential sentiment shifts.

03

What to watch

No 10b5-1 plan; sale spread over multiple days may indicate strategic timing.

Relevance 7/10Novelty 6/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$ELBearishMedium confidence
Context

Director Paul J. Fribourg sold 103,000 shares for $10.0M, reducing his stake to 417,300 shares.

Expected impact

Potential short-term pressure on EL price.

Evidence & confidence

Large $10M sale by a director could influence investor perception despite no 10b5-1 plan.

Market effects

May raise concerns for the cosmetics sector if other insiders follow.

Limited to US equity markets.

Low global impact.

Counterpoint

Insider sell could be routine portfolio rebalancing, not a red flag.

Key entities

  • Estee Lauder Companies Inc.

    US-listed cosmetics and fragrance company.

  • Paul J. Fribourg

    Director of Estee Lauder who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$ELHighAI 8/10

Estée Lauder’s (EL) Turnaround Story Just Got Real Numbers Behind It

Estée Lauder (EL) reported fiscal 2026 Q4 and full-year earnings, showing organic net sales up 3%, adjusted operating margin at 11.2%, and adjusted diluted EPS at $2.51. Fragrance and Skin Care led growth, with Jo Malone and TOM FORD joining the billion-dollar brand club. The company guided fiscal 2027 organic sales growth of 3% to 5% and adjusted operating margin of 12.7% to 13.5%. Challenges include Middle East conflict impacts and Hair Care declines. Hedge fund ownership held steady at 47 fun

$ELHighAI 9/10

Estée Lauder (EL) Q4 2026 Earnings Call Transcript

Estée Lauder (EL) reported 3% organic net sales growth for fiscal 2026, with adjusted EPS of $2.51, up 66%. Key drivers included 10% fragrance sales growth and 9% growth in Mainland China. Guidance for fiscal 2027 includes 3-5% organic sales growth and adjusted EPS of $3.10-$3.35. Management highlighted margin expansion and strategic initiatives, including headcount reductions and digital investments.